Tilt balance towards regulation: evolving new strategy for treatment of hemophilia inhibitors.

about

Progress toward inducing immunologic tolerance to factor VIII.Complexity of immune responses to AAV transgene products - Example of factor IX.Gene Therapy With Regulatory T Cells: A Beneficial Alliance.

P2860

Q38090391-C0B20909-9503-4348-8C14-AC1B59D346FC Q39394803-1D8E2B86-1503-44F3-8BC9-57A0FFADCDFC Q52721830-4674CEE0-AF91-4021-899C-59DCA576541A

P2860

Tilt balance towards regulation: evolving new strategy for treatment of hemophilia inhibitors.

Item

http://www.wikidata.org/entity/Q42839182

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Tilt balance towards regulatio ...... ment of hemophilia inhibitors.

@en

Tilt balance towards regulatio ...... ment of hemophilia inhibitors.

@nl

type

Item

label

Tilt balance towards regulatio ...... ment of hemophilia inhibitors.

@en

Tilt balance towards regulatio ...... ment of hemophilia inhibitors.

@nl

prefLabel

Tilt balance towards regulatio ...... ment of hemophilia inhibitors.

@en

Tilt balance towards regulatio ...... ment of hemophilia inhibitors.

@nl

P1476

Tilt balance towards regulatio ...... ment of hemophilia inhibitors.

@en

P2093

C H Miao

http://www.w3.org/2001/XMLSchema#string

P2860

An oscillatory switch in mTOR kinase activity sets regulatory T cell responsiveness.

In vivo expansion of regulatory T cells with IL-2/IL-2 mAb complexes prevents anti-factor VIII immune responses in hemophilia A mice treated with factor VIII plasmid-mediated gene therapy.

Immunomodulation of transgene responses following naked DNA transfer of human factor VIII into hemophilia A mice

Hematopoietic stem-cell gene therapy of hemophilia A incorporating a porcine factor VIII transgene and nonmyeloablative conditioning regimens.

Strategies towards a longer acting factor VIII.

Transient blockade of the inducible costimulator pathway generates long-term tolerance to factor VIII after nonviral gene transfer into hemophilia A mice

Factor VIII inhibitors: risk factors and methods for prevention and immune modulation.

Anti-CD3 antibodies modulate anti-factor VIII immune responses in hemophilia A mice after factor VIII plasmid-mediated gene therapy.

The molecular mechanisms of immunomodulation and tolerance induction to factor VIII.

Factor VIII-specific B cell responses in haemophilia A patients with inhibitors.

P304

1521-1523

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1538-7836.2011.04391.X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2011-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51199200

http://www.w3.org/2001/XMLSchema#string

P698

21649848

http://www.w3.org/2001/XMLSchema#string

P921

hemophilia

P932

4549066

http://www.w3.org/2001/XMLSchema#string

Tilt balance towards regulation: evolving new strategy for treatment of hemophilia inhibitors.

about

P2860

P2860

Tilt balance towards regulation: evolving new strategy for treatment of hemophilia inhibitors.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P932